XRAY

Business Context and Reporting Period

Company: DENTSPLY International Inc.
Filing Type: Form 10-K (Annual Report)
Period Ended: December 31, 1998
Business Overview: DENTSPLY designs, develops, manufactures, and markets dental consumable and laboratory products (e.g., prosthetics, endodontic instruments, impression materials) and dental equipment (e.g., x-ray systems, handpieces, intraoral cameras). The company operates in over 100 countries with approximately 6,000 employees. In 1998, the company pursued an aggressive acquisition strategy, purchasing seven businesses including GAC International, Vereingte Dentalwerke GmbH (VDW), and InfoSoft.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Growth: Net sales increased 10.3% to $795.1 million. Acquisitions contributed 7.0% of this growth, while base business sales grew 4.3% (driven by 7.7% growth in the U.S. and 2.1% in Europe).
• Profitability Decline: Net income decreased 53.4% to $34.8 million. This decline was primarily driven by $71.5 million in pre-tax restructuring and other costs.
• Restructuring Charges:
  • Q2 1998: $29.0 million charge for rationalizing the worldwide laboratory business (closing German tooth facility) and terminating implant product arbitration costs.
  • Q4 1998: $42.5 million charge to integrate the New Image intraoral camera line into Gendex, including write-offs of intangibles and goodwill.
• Debt Increase: Total debt increased to $233.8 million from $129.5 million, largely due to $106.8 million spent on acquisitions and $42.0 million used for stock repurchases.
• Stock Repurchases: The company repurchased 1.8 million shares of common stock for $42.0 million in 1998.

Guidance, Outlook, Risks, and Unusual Items

• Outlook: Management expects the restructuring of the laboratory business and New Image division to be completed by the end of the second quarter of 1999, with benefits realized by the end of 1999. The company anticipates continued growth in the U.S. market due to demographic trends (aging population) and increased focus on preventive and cosmetic dentistry.
• Year 2000 Compliance: The company is upgrading IT systems to be Year 2000 compliant, with an anticipated completion date of mid-1999. Total project costs to date are approximately $14.5 million, with an additional $2.3 million anticipated for 1999.
• Legal Proceedings: In January 1999, the U.S. Department of Justice filed an antitrust complaint alleging violations regarding the distribution of artificial teeth by the Trubyte Division. A private class action suit was also filed. Management believes these will not have a material adverse effect.
• Foreign Currency Risk: Approximately 46% of sales are generated outside the U.S. A strong U.S. dollar negatively impacts reported revenues and operating results. The company uses forward contracts to hedge major exposures.
• Unusual Items: The $71.5 million in restructuring charges are non-recurring. Excluding these costs, income before taxes would have increased 3.8% and net income would have increased 7.6% compared to 1997.

Investor Verification Checklist

• Restructuring Execution: Verify the timeline and cost savings associated with the closure of the German tooth manufacturing facility and the New Image division integration.
• Acquisition Integration: Assess the financial performance and integration progress of the seven 1998 acquisitions, particularly GAC International and VDW.
• Antitrust Litigation: Monitor the status of the DOJ antitrust investigation and the private class action suit regarding artificial teeth distribution.
• Year 2000 Costs: Confirm that IT upgrades are completed on schedule and that no significant operational disruptions or additional costs arise from third-party non-compliance.
• Debt Servicing: Review the company's ability to service increased debt levels ($233.8 million) given the reduction in operating income.